Skip to main content
Fig. 5 | Diagnostic Pathology

Fig. 5

From: TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer

Fig. 5

Changes in MDR1 expression in primary and recurrent lesions between the TP53 wild-type and mutant groups detected by immunohistochemistry. First row: TP53 wild-type group, second row: TP53 mutant group. The first column indicates P53 expression, the second column indicates MDR1 expression in primary lesions, and the third column indicates MDR1 expression in relapse tissues. (×200)

Back to article page